Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Position Trimmed by West Branch Capital LLC

West Branch Capital LLC trimmed its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 26.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,632 shares of the pharmacy operator’s stock after selling 600 shares during the quarter. West Branch Capital LLC’s holdings in Walgreens Boots Alliance were worth $43,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vontobel Holding Ltd. boosted its position in Walgreens Boots Alliance by 104.6% during the first quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock valued at $1,752,000 after purchasing an additional 18,879 shares during the last quarter. Moors & Cabot Inc. raised its stake in shares of Walgreens Boots Alliance by 31.1% during the 1st quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock worth $931,000 after purchasing an additional 4,931 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 27.9% during the 1st quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock valued at $339,000 after buying an additional 1,651 shares during the last quarter. Candriam Luxembourg S.C.A. lifted its holdings in shares of Walgreens Boots Alliance by 0.5% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock valued at $2,842,000 after buying an additional 310 shares during the last quarter. Finally, Baird Financial Group Inc. grew its stake in shares of Walgreens Boots Alliance by 14.2% in the 1st quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock valued at $20,932,000 after buying an additional 58,184 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average cost of $22.44 per share, with a total value of $99,992.64. Following the completion of the transaction, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett purchased 4,456 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the transaction, the director now directly owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Nancy M. Schlichting sold 15,209 shares of the firm’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total transaction of $350,567.45. The disclosure for this sale can be found here. Corporate insiders own 17.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on WBA shares. SVB Leerink reduced their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Barclays assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 price objective on the stock. Finally, Bank of America decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $25.00.

View Our Latest Research Report on WBA

Walgreens Boots Alliance Trading Up 3.2 %

Shares of Walgreens Boots Alliance stock opened at $21.69 on Friday. Walgreens Boots Alliance, Inc. has a 1 year low of $19.68 and a 1 year high of $36.58. The company’s fifty day simple moving average is $21.71 and its 200-day simple moving average is $22.27. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.30 and a current ratio of 0.66.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period in the prior year, the firm earned $1.16 EPS. The business’s revenue was up 6.3% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 3.25 earnings per share for the current fiscal year.

Walgreens Boots Alliance Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th were paid a dividend of $0.25 per share. The ex-dividend date was Friday, February 16th. This represents a $1.00 annualized dividend and a yield of 4.61%. Walgreens Boots Alliance’s dividend payout ratio is -14.29%.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.